C168H232ClF2N19O13 — CID 157208930
(2R)-2-(2-chlorophenyl)-2-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]-4-hydroxypiperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;bis((2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-hydroxy-4-[3-(tetrazolo[1,5-a]pyridin-6-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid);(3R)-3-[(3S,4S)-3-[[4-hydroxy-4-(3-quinolin-3-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-4-methylpentan-2-one;methane (PubChem CID 157208930) has the molecular formula C168H232ClF2N19O13 and a molecular weight of 2799.27 g/mol. Its IUPAC name is (2R)-2-(2-chlorophenyl)-2-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]-4-hydroxypiperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;bis((2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-hydroxy-4-[3-(tetrazolo[1,5-a]pyridin-6-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid);(3R)-3-[(3S,4S)-3-[[4-hydroxy-4-(3-quinolin-3-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-4-methylpentan-2-one;methane.
| Compound Name | (2R)-2-(2-chlorophenyl)-2-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]-4-hydroxypiperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;bis((2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-hydroxy-4-[3-(tetrazolo[1,5-a]pyridin-6-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid);(3R)-3-[(3S,4S)-3-[[4-hydroxy-4-(3-quinolin-3-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-4-methylpentan-2-one;methane |
|---|---|
| PubChem CID | 157208930 |
| Molecular Formula | C168H232ClF2N19O13 |
| Molecular Weight | 2799.27 g/mol |
| Exact Mass | 2796.77 |
| IUPAC Name | (2R)-2-(2-chlorophenyl)-2-[(3S,4S)-3-phenyl-4-[[4-(3-phenylpropyl)piperidin-1-yl]methyl]pyrrolidin-1-yl]acetic acid;(2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-[3-(3,4-difluorophenyl)propyl]-4-hydroxypiperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid;bis((2R)-2-cyclohexyl-2-[(3S,4S)-3-[[4-hydroxy-4-[3-(tetrazolo[1,5-a]pyridin-6-yl)propyl]piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]acetic acid);(3R)-3-[(3S,4S)-3-[[4-hydroxy-4-(3-quinolin-3-ylpropyl)piperidin-1-yl]methyl]-4-phenylpyrrolidin-1-yl]-4-methylpentan-2-one;methane |
| SMILES | C.C.C.C.CC(=O)[C@@H](C(C)C)N1C[C@H](CN2CCC(O)(CCCc3cnc4ccccc4c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccc(F)c(F)c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccc4nnnn4c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccc4nnnn4c3)CC2)[C@@H](c2ccccc2)C1.O=C(O)[C@@H](c1ccccc1Cl)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 |
| InChI | InChI=1S/C34H45N3O2.C33H39ClN2O2.C33H44F2N2O3.2C32H44N6O3.4CH4/c1-25(2)33(26(3)38)37-23-30(31(24-37)28-11-5-4-6-12-28)22-36-18-16-34(39,17-19-36)15-9-10-27-20-29-13-7-8-14-32(29)35-21-27;34-31-17-8-7-16-29(31)32(33(37)38)36-23-28(30(24-36)27-14-5-2-6-15-27)22-35-20-18-26(19-21-35)13-9-12-25-10-3-1-4-11-25;34-29-14-13-24(20-30(29)35)8-7-15-33(40)16-18-36(19-17-33)21-27-22-37(23-28(27)25-9-3-1-4-10-25)31(32(38)39)26-11-5-2-6-12-26;2*39-31(40)30(26-11-5-2-6-12-26)37-22-27(28(23-37)25-9-3-1-4-10-25)21-36-18-16-32(41,17-19-36)15-7-8-24-13-14-29-33-34-35-38(29)20-24;;;;/h4-8,11-14,20-21,25,30-31,33,39H,9-10,15-19,22-24H2,1-3H3;1-8,10-11,14-17,26,28,30,32H,9,12-13,18-24H2,(H,37,38);1,3-4,9-10,13-14,20,26-28,31,40H,2,5-8,11-12,15-19,21-23H2,(H,38,39);2*1,3-4,9-10,13-14,20,26-28,30,41H,2,5-8,11-12,15-19,21-23H2,(H,39,40);4*1H4/t30-,31+,33+;28-,30+,32+;27-,28+,31+;2*27-,28+,30+;;;;/m00000..../s1 |
| InChIKey | ARQZMCYJEXDZMZ-PQKQSBKGSA-N |
| XLogP | 29.08 |
| TPSA | 378.64 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 203 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2799.27 |
| LogP ≤ 5 | 29.08 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 28 |